Selective plasma protein binding of antimalarial drugs to α1-acid glycoprotein

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 7, 2008, Pages 3759-3772

  Zsila, Ferenc ^a   Visy, Júlia ^a   Mády, György ^a   Fitos, Ilona ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

Acute phase reaction; Antimalarial drugs; Fluorescence probes; Genetic variants; Human serum 1 acid glycoprotein; Human serum albumin; Induced circular dichroism; Malaria; Plasma protein binding; Stereoselective binding

Indexed keywords

AMODIAQUINE; CHLOROQUINE; MEFLOQUINE; MEPACRINE; OROSOMUCOID; PRIMAQUINE; QUINOLINE; TAFENOQUINE;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; DRUG SELECTIVITY; FLUORESCENCE ANALYSIS; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; PLASMA PROTEIN BINDING; SPECTROSCOPY; STEREOCHEMISTRY; ULTRAFILTRATION; ULTRAVIOLET SPECTROSCOPY;

ANTIMALARIALS; BINDING SITES; CHROMATOGRAPHY, AFFINITY; CIRCULAR DICHROISM; HUMANS; MOLECULAR STRUCTURE; OROSOMUCOID; PROTEIN BINDING; SERUM ALBUMIN; SPECTROPHOTOMETRY; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 41649093951     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.01.053     Document Type: Article

References (54)

1. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., and Curry S. J. Mol. Biol. 353 (2005) 38-52
2. Israili Z.H., and Dayton P.G. Drug Metab. Rev. 33 (2001) 161-235
3. Breustedt D.A., Schonfeld D.L., and Skerra A. Biochim. Biophys. Acta 1764 (2006) 161-173
4. Herve F., Caron G., Duche J.C., Gaillard P., Abd Rahman N., Tsantili-Kakoulidou A., Carrupt P.A., d'Athis P., Tillement J.P., and Testa B. Mol. Pharmacol. 54 (1998) 129-138
5. Fitos I., Visy J., Zsila F., Bikadi Z., Mady G., and Simonyi M. Biochem. Pharmacol. 67 (2004) 679-688
6. Tomei L., Eap C.B., Baumann P., and Dente L. Hum. Genet. 84 (1989) 89-91
7. Hochepied T., Berger F.G., Baumann H., and Libert C. Cytokine Growth Factor Rev. 14 (2003) 25-34
8. Ritchie R.F., Palomaki G.E., Neveux L.M., Navolotskaia O., Ledue T.B., and Craig W.Y. J. Clin. Lab. Anal. 13 (1999) 273-279
9. Kremer J.M., Wilting J., and Janssen L.H. Pharmacol. Rev. 40 (1988) 1-47
10. Vangapandu S., Jain M., Kaur K., Patil P., Patel S.R., and Jain R. Med. Res. Rev. 27 (2007) 65-107
11. Wallace D.J. Semin. Arthritis. Rheum. 18 (1989) 282-296
12. Borden M.B., and Parke A.L. Drug Saf. 24 (2001) 1055-1063
13. Graninger W., Thalhammer F., Hollenstein U., Zotter G.M., and Kremsner P.G. Acta Trop. 52 (1992) 121-128
14. Jagadeesan V., and Krishnaswamy K. Eur. J. Clin. Pharmacol. 27 (1985) 657-659
15. Mansor S.M., Molyneux M.E., Taylor T.E., Ward S.A., Wirima J.J., and Edwards G. Br. J. Clin. Pharmacol. 32 (1991) 317-321
16. Wanwimolruk S., and Denton J.R. J. Pharm. Pharmacol. 44 (1992) 806-811
17. Zsila F., and Iwao Y. Biochim. Biophys. Acta 1770 (2007) 797-809
18. Zsila F., Matsunaga H., Bikadi Z., and Haginaka J. Biochim. Biophys. Acta 1760 (2006) 1248-1273
19. Zsila F., Bikádi Z., Fitos I., and Simonyi M. Curr. Drug Discov. Technol. 1 (2004) 133-153
20. Ascoli G.A., Domenici E., and Bertucci C. Chirality 18 (2006) 667-679
21. Maruyama T., Otagiri M., and Takadate A. Chem. Pharm. Bull. (Tokyo) 38 (1990) 1688-1691
22. Nishi K., Fukunaga N., and Otagiri M. Drug Metab. Dispos. 32 (2004) 1069-1074
23. Hazai E., Visy J., Fitos I., Bikadi Z., and Simonyi M. Bioorg. Med. Chem. 14 (2006) 1959-1965
24. Albani J.R. Carbohydr. Res. 339 (2004) 607-612
25. Herve F., Gomas E., Duche J.C., and Tillement J.P. Br. J. Clin. Pharmacol. 36 (1993) 241-249
26. Sudlow G., Birkett D.J., and Wade D.N. Mol. Pharmacol. 12 (1976) 1052-1061
27. Fitos I., Visy J., Simonyi M., and Hermansson J. Chirality 5 (1993) 346-349
28. Albani J.R. Carbohydr. Res. 341 (2006) 2557-2564
29. Ross P.D., and Subramanian S. Biochemistry 20 (1981) 3096-3102
30. Lakowicz J.R. Principles of Fluorescence Spectroscopy (2006), Springer 185-210
31. Ducharme J., and Farinotti R. Clin. Pharmacokinet. 31 (1996) 257-274
32. Gimenez F., Pennie R.A., Koren G., Crevoisier C., Wainer I.W., and Farinotti R. J. Pharm. Sci. 83 (1994) 824-827
33. Mu J.Y., Israili Z.H., and Dayton P.G. Drug Metab. Dispos. 3 (1975) 198-210
34. Giao P.T., and de Vries P.J. Clin. Pharmacokinet. 40 (2001) 343-373
35. Kennedy E., and Frischer H. J. Lab. Clin. Med. 116 (1990) 871-878
36. Duche J.C., Urien S., Simon N., Malaurie E., Monnet I., and Barre J. Clin. Biochem. 33 (2000) 197-202
37. Eap C.B., Fischer J.F., and Baumann P. Clin. Chim. Acta 203 (1991) 379-385
38. Olliaro P.L., and Taylor W.R. J. Postgrad. Med. 50 (2004) 40-44
39. Wanwimolruk S., Edwards G., Ward S.A., and Breckenridge A.M. J. Pharm. Pharmacol. 44 (1992) 940-942
40. Colussi D., Parisot C., Legay F., and Lefevre G. Eur. J. Pharm. Sci. 9 (1999) 9-16
41. Spizek J., and Rezanka T. Appl. Microbiol. Biotechnol. 64 (2004) 455-464
42. Nakornchai S., and Konthiang P. Acta Trop. 100 (2006) 185-191
43. Brocks D.R., and Mehvar R. Clin. Pharmacokinet. 42 (2003) 1359-1382
44. Webster R.V., Craig J.C., Shyamala V., Kirby G.C., and Warhurst D.C. Biochem. Pharmacol. 42 (1991) S225-S227
45. Bourahla A., Martin C., Gimenez F., Singhasivanon V., Attanath P., Sabchearon A., Chongsuphajaisiddhi T., and Farinotti R. Eur. J. Clin. Pharmacol. 50 (1996) 241-244
46. Karle J.M., and Karle I.L. Antimicrob. Agents Chemother. 46 (2002) 1529-1534
47. Karle J.M., Olmeda R., Gerena L., and Milhous W.K. Exp. Parasitol. 76 (1993) 345-351
48. Fitos I., Tegyey Z., Simonyi M., Sjoholm I., Larsson T., and Lagercrantz C. Biochem. Pharmacol. 35 (1986) 263-269
49. Fitos I., Visy J., Zsila F., Mády G., and Simonyi M. Biochim. Biophys. Acta 1760 (2006) 1704-1712
50. 1-Acid Glycoprotein: From Basic Sciences to Clinical Applications; Kumamoto, Japan, 2000; p. 45.
51. Zsila F., Bikádi Z., and Simonyi M. Biochem. Pharmacol. 65 (2003) 447-456
52. Woody R.W. Methods Enzymol. 246 (1995) 34-71
53. Aubry A.F., Gimenez F., Farinotti R., and Wainer I.W. Chirality 4 (1992) 30-35
54. Wallen L., Ericsson O., Wikstrom I., and Hellgren U. J. Chromatogr. B Biomed. Appl. 655 (1994) 153-157